Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 18, 2022

DOAC Use for Atrial Fibrillation After TAVR Leads to Fewer Bleeds and Deaths

Journal of the American Heart Association


Additional Info

Journal of the American Heart Association
Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry
J Am Heart Assoc 2022 Jan 04;11(1)e023561, T Tanawuttiwat, A Stebbins, G Marquis-Gravel, S Vemulapalli, AS Kosinski, A Cheng

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading